Page 45 - Haematologica July

Setd2 regulates hematopoietic stem cells
mediated histone H3.3 deposition. EMBO J.
2013;32(17):2392-2406.
33. Shen C, Ipsaro JJ, Shi J, et al. NSD3-Short Is
an Adaptor Protein that Couples BRD4 to the CHD8 Chromatin Remodeler. Mol Cell. 2015;60(6):847-859.
34. Rahman S, Sowa ME, Ottinger M, et al. The Brd4 extraterminal domain confers tran- scription activation independent of pTEFb by recruiting multiple proteins, including NSD3. Mol Cell Biol. 2011;31(13):2641- 2652.
35. Jang MK, Mochizuki K, Zhou M, et al. The bromodomain protein Brd4 is a positive reg- ulatory component of P-TEFb and stimu- lates RNA polymerase II-dependent tran- scription. Mol Cell. 2005;19(4):523-534.
36. Yang Z, Yik JH, Chen R, et al. Recruitment of P-TEFb for stimulation of transcriptional elongation by the bromodomain protein Brd4. Mol Cell. 2005;19(4):535-545.
37. Benedikt A, Baltruschat S, Scholz B, et al. The leukemogenic AF4-MLL fusion protein causes P-TEFb kinase activation and altered epigenetic signatures. Leukemia. 2011;25(1): 135-144.
38. Haferlach T, Nagata Y, Grossmann V, et al. Landscape of genetic lesions in 944 patients with myelodysplastic syndromes. Leukemia. 2014;28(2):241-247.
39. Della Porta MG, Malcovati L. Myelodysplastic syndromes with bone mar- row fibrosis. Haematologica. 2011;96(2): 180-183.
40. Arber DA, Orazi A, Hasserjian R, et al. The 2016 revision to the World Health Organization classification of myeloid neo- plasms and acute leukemia. Blood. 2016;127(20):2391-2405.
41. Busch K, Klapproth K, Barile M, et al. Fundamental properties of unperturbed haematopoiesis from stem cells in vivo. Nature. 2015;518(7540):542-546.
42. Bu J, Chen A, Yan X, et al. SETD2-mediated crosstalk between H3K36me3 and H3K79me2 in MLL-rearranged leukemia. Leukemia. 2018;32(4):890-899.
43. Mar BG, Chu SH, Kahn JD, et al. SETD2 alterations impair DNA damage recognition and lead to resistance to chemotherapy in leukemia. Blood. 2017;130(24):2631-2641.
haematologica | 2018; 103(7)
1123